[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "",
    "text": "Study Objective: Investigate the association between obstructive sleep apnea (OSA) and in-hospital outcomes in patients admitted with a diagnosis of renal failure across U.S. hospitals from 2018 to 2020, adjusting for demographic, clinical, and hospital factors.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) from 2018 to 2020, a nationwide database that captures inpatient admissions in the U.S., and is weighted to provide nationally representative estimates.\nPatient Selection: Included all inpatient admissions with a diagnosis of renal failure, identified using ICD-10-CM codes N18.5xx (Stage 5 CKD) and N18.6xx (ESRD). Patients were categorized based on the presence or absence of obstructive sleep apnea, identified using ICD-10-CM code G47.33.\nOutcomes of Interest:\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nCardiac arrest\nGastrointestinal hemorrhage\n\n\nAdjustment Variables:\n\nDemographics and Socioeconomic Factors: Age, sex, race, residential income quartile.\nHospital Characteristics: Region, bed size, and teaching status.\nClinical Factors: Kidney transplant history, coronary artery disease, cerebrovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, heart failure, hypertension, obesity, and Charlson Comorbidity Index.\n\nStatistical Analysis:\n\nUnivariable Analysis:\n\nContinuous Outcomes: Design-based Kruskal-Wallis test for outcomes such as length of stay and total charges.\nCategorical Outcomes: Rao & Scott-adjusted Pearson’s Chi-square test for outcomes like in-hospital mortality, gastrointestinal bleeding, and cardiac arrest.\n\nMultivariable Analysis:\n\nLogistic Regression: For binary outcomes (e.g., in-hospital mortality, gastrointestinal bleeding, cardiac arrest). Report adjusted odds ratios (ORs) with 95% confidence intervals (CIs).\nLinear Regression: For continuous outcomes (e.g., length of stay, total charges). Report adjusted beta coefficients with 95% CIs.\n\nModel Adjustment: All models adjusted for the demographic, clinical, and hospital factors listed above, as well as OSA status (yes/no).\nSurvey Weights: The NIS survey design and discharge weights were applied to account for the complex sampling methodology and ensure nationally representative estimates.\n\nSoftware: All analyses were conducted using the R Statistical Language (Version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria), utilizing the survey package to account for complex sampling designs of the NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "",
    "text": "Study Objective: Investigate the association between obstructive sleep apnea (OSA) and in-hospital outcomes in patients admitted with a diagnosis of renal failure across U.S. hospitals from 2018 to 2020, adjusting for demographic, clinical, and hospital factors.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) from 2018 to 2020, a nationwide database that captures inpatient admissions in the U.S., and is weighted to provide nationally representative estimates.\nPatient Selection: Included all inpatient admissions with a diagnosis of renal failure, identified using ICD-10-CM codes N18.5xx (Stage 5 CKD) and N18.6xx (ESRD). Patients were categorized based on the presence or absence of obstructive sleep apnea, identified using ICD-10-CM code G47.33.\nOutcomes of Interest:\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nCardiac arrest\nGastrointestinal hemorrhage\n\n\nAdjustment Variables:\n\nDemographics and Socioeconomic Factors: Age, sex, race, residential income quartile.\nHospital Characteristics: Region, bed size, and teaching status.\nClinical Factors: Kidney transplant history, coronary artery disease, cerebrovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, heart failure, hypertension, obesity, and Charlson Comorbidity Index.\n\nStatistical Analysis:\n\nUnivariable Analysis:\n\nContinuous Outcomes: Design-based Kruskal-Wallis test for outcomes such as length of stay and total charges.\nCategorical Outcomes: Rao & Scott-adjusted Pearson’s Chi-square test for outcomes like in-hospital mortality, gastrointestinal bleeding, and cardiac arrest.\n\nMultivariable Analysis:\n\nLogistic Regression: For binary outcomes (e.g., in-hospital mortality, gastrointestinal bleeding, cardiac arrest). Report adjusted odds ratios (ORs) with 95% confidence intervals (CIs).\nLinear Regression: For continuous outcomes (e.g., length of stay, total charges). Report adjusted beta coefficients with 95% CIs.\n\nModel Adjustment: All models adjusted for the demographic, clinical, and hospital factors listed above, as well as OSA status (yes/no).\nSurvey Weights: The NIS survey design and discharge weights were applied to account for the complex sampling methodology and ensure nationally representative estimates.\n\nSoftware: All analyses were conducted using the R Statistical Language (Version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria), utilizing the survey package to account for complex sampling designs of the NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Baseline Table:",
    "text": "Baseline Table:\nA total of 3,385,755 hospitalizations with a diagnosis of renal failure were identified, of which 362,855 (10.7%) involved patients with a concurrent diagnosis of obstructive sleep apnea (OSA). Patients with OSA were more likely to be older (mean age: 63 ± 12 vs. 62 ± 15 years; p &lt; 0.001) and male (61% vs. 54%; p &lt; 0.001) compared to those without OSA. The racial distribution differed significantly, with a higher proportion of White patients in the OSA group (52% vs. 40%) and lower representation among Asian/Pacific Islander, Hispanic, and Other racial categories (p &lt; 0.001).\nSocioeconomic indicators showed that patients with OSA were more likely to reside in higher-income quartiles (16% in the highest quartile vs. 14%; p &lt; 0.001). Medicare was the predominant payer for patients with OSA (79% vs. 72%; p &lt; 0.001). Geographically, OSA patients were more commonly hospitalized in the Midwest (30% vs. 19%) and less so in the South (39% vs. 44%; p &lt; 0.001).\nComorbidity patterns revealed that patients with OSA had significantly higher rates of coronary artery disease (53% vs. 41%), diabetes mellitus (74% vs. 63%), heart failure (63% vs. 49%), hypertension (96% vs. 95%), and obesity (44% vs. 15%; all p &lt; 0.001).\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 3,385,7551\nRenal Failure without OSA N = 3,022,9001\nRenal Failure with OSA N = 362,8551\np-value2\n\n\n\n\nAge, y\n62 (15)\n62 (15)\n63 (12)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n1,537,500 (45%)\n1,397,280 (46%)\n140,220 (39%)\n\n\n\n\n    Male\n1,848,165 (55%)\n1,625,530 (54%)\n222,635 (61%)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n1,380,020 (42%)\n1,196,370 (40%)\n183,650 (52%)\n\n\n\n\n    Asian or Pacific Islander\n138,215 (4.2%)\n128,165 (4.3%)\n10,050 (2.8%)\n\n\n\n\n    Black\n1,105,220 (33%)\n989,245 (33%)\n115,975 (33%)\n\n\n\n\n    Hispanic\n558,465 (17%)\n522,820 (18%)\n35,645 (10%)\n\n\n\n\n    Other\n141,300 (4.3%)\n131,705 (4.4%)\n9,595 (2.7%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n1,297,295 (39%)\n1,171,690 (39%)\n125,605 (35%)\n\n\n\n\n    $52,000 - $65,999\n858,270 (26%)\n762,255 (26%)\n96,015 (27%)\n\n\n\n\n    $66,000 - $87,999\n692,500 (21%)\n612,270 (21%)\n80,230 (22%)\n\n\n\n\n    $88,000 or more\n482,110 (14%)\n425,735 (14%)\n56,375 (16%)\n\n\n\n\nInsurance payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Medicaid\n429,845 (13%)\n402,960 (13%)\n26,885 (7.4%)\n\n\n\n\n    Medicare\n2,471,650 (73%)\n2,186,840 (72%)\n284,810 (79%)\n\n\n\n\n    Other\n113,830 (3.4%)\n104,920 (3.5%)\n8,910 (2.5%)\n\n\n\n\n    Private\n367,220 (11%)\n325,285 (11%)\n41,935 (12%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n673,010 (20%)\n564,770 (19%)\n108,240 (30%)\n\n\n\n\n    Northeast\n555,475 (16%)\n503,840 (17%)\n51,635 (14%)\n\n\n\n\n    South\n1,475,535 (44%)\n1,333,720 (44%)\n141,815 (39%)\n\n\n\n\n    West\n681,735 (20%)\n620,570 (21%)\n61,165 (17%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n1,776,065 (52%)\n1,576,025 (52%)\n200,040 (55%)\n\n\n\n\n    Medium\n985,185 (29%)\n885,455 (29%)\n99,730 (27%)\n\n\n\n\n    Small\n624,505 (18%)\n561,420 (19%)\n63,085 (17%)\n\n\n\n\nHospital location/teaching status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n174,185 (5.1%)\n155,975 (5.2%)\n18,210 (5.0%)\n\n\n\n\n    Urban, non-teaching\n602,090 (18%)\n546,315 (18%)\n55,775 (15%)\n\n\n\n\n    Urban, teaching\n2,609,480 (77%)\n2,320,610 (77%)\n288,870 (80%)\n\n\n\n\nKidney transplant Hx\n71,600 (2.1%)\n63,945 (2.1%)\n7,655 (2.1%)\n&gt;0.9\n\n\nCoronary artery disease\n1,442,975 (43%)\n1,250,625 (41%)\n192,350 (53%)\n&lt;0.001\n\n\nCerebrovascular disease\n301,515 (8.9%)\n272,070 (9.0%)\n29,445 (8.1%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n821,050 (24%)\n680,090 (22%)\n140,960 (39%)\n&lt;0.001\n\n\nDiabetes mellitus\n2,169,300 (64%)\n1,901,405 (63%)\n267,895 (74%)\n&lt;0.001\n\n\nHeart failure\n1,704,180 (50%)\n1,475,125 (49%)\n229,055 (63%)\n&lt;0.001\n\n\nHIV/AIDS\n32,890 (1.0%)\n31,080 (1.0%)\n1,810 (0.5%)\n&lt;0.001\n\n\nHypertension\n3,212,090 (95%)\n2,863,345 (95%)\n348,745 (96%)\n&lt;0.001\n\n\nObesity\n617,580 (18%)\n457,975 (15%)\n159,605 (44%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\nUpon univariable analysis, patients with OSA had significantly lower in-hospital mortality rates compared to those without OSA (4.0% vs. 5.5%; p &lt; 0.001). Cardiac arrest was less frequent among OSA patients (1.9% vs. 2.4%; p &lt; 0.001), while rates of gastrointestinal hemorrhage were comparable between groups (8.3% vs. 8.4%; p = 0.2). The median length of stay was longer for OSA patients (5.0 [3.0–8.0] vs. 4.0 [2.0–8.0] days; p &lt; 0.001), whereas total hospital charges were not significantly different after inflation adjustment ($52,011 vs. $51,542; p = 0.2).\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 3,385,7551\nRenal Failure without OSA N = 3,022,9001\nRenal Failure with OSA N = 362,8551\np-value2\n\n\n\n\nDied during hospitalization\n182,145 (5.4%)\n167,595 (5.5%)\n14,550 (4.0%)\n&lt;0.001\n\n\nCardiac arrest\n80,210 (2.4%)\n73,245 (2.4%)\n6,965 (1.9%)\n&lt;0.001\n\n\nGastrointestinal hemorrhage\n284,705 (8.4%)\n254,620 (8.4%)\n30,085 (8.3%)\n0.2\n\n\nLength of stay (days)\n4.0 (2.0, 8.0)\n4.0 (2.0, 8.0)\n5.0 (3.0, 8.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n51,600 (27,248, 104,284)\n51,542 (27,132, 104,617)\n52,011 (28,186, 101,495)\n0.2\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-regression",
    "href": "quarto/index.html#multivariable-regression",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Multivariable Regression:",
    "text": "Multivariable Regression:\nAfter adjustment for demographic, clinical, and hospital factors, OSA was associated with reduced odds of in-hospital mortality (adjusted OR 0.72; 95% CI 0.70–0.76; p &lt; 0.001). OSA also conferred a protective effect against cardiac arrest (adjusted OR 0.74; 95% CI 0.70–0.79; p &lt; 0.001). However, no significant association was observed between OSA and gastrointestinal hemorrhage (adjusted OR 1.01; 95% CI 0.98–1.05; p = 0.3).\nOSA was associated with a modest reduction in length of stay (adjusted β = -0.39 days; 95% CI -0.46 to -0.32; p &lt; 0.001) and inflation-adjusted total hospital charges (adjusted β = -$10,138; 95% CI -$11,494 to -$8,782; p &lt; 0.001).\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n0.72\n0.70, 0.76\n&lt;0.001\n\n\nAge, y\n1.03\n1.03, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.04\n1.02, 1.07\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.92\n0.87, 0.98\n0.007\n\n\n    Black\n0.86\n0.84, 0.89\n&lt;0.001\n\n\n    Hispanic\n0.89\n0.86, 0.93\n&lt;0.001\n\n\n    Other\n1.07\n1.01, 1.14\n0.016\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.94\n0.91, 0.97\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.90\n0.87, 0.93\n&lt;0.001\n\n\n    $88,000 or more\n0.92\n0.88, 0.95\n&lt;0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.92\n0.88, 0.96\n&lt;0.001\n\n\n    Other\n1.67\n1.55, 1.80\n&lt;0.001\n\n\n    Private\n1.20\n1.14, 1.27\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.16\n1.10, 1.22\n&lt;0.001\n\n\n    South\n1.12\n1.08, 1.17\n&lt;0.001\n\n\n    West\n1.20\n1.14, 1.25\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.96\n0.93, 1.00\n0.041\n\n\n    Small\n0.89\n0.85, 0.92\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.00\n0.94, 1.07\n&gt;0.9\n\n\n    Urban, teaching\n1.14\n1.07, 1.21\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.86, 1.02\n0.2\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n1.00, 1.05\n0.10\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.38\n1.34, 1.43\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.74, 0.79\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.59\n0.58, 0.61\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.31\n1.28, 1.34\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.37\n0.33, 0.42\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.41\n0.40, 0.43\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.89, 0.95\n&lt;0.001\n\n\nCharlson comorbidity index\n1.21\n1.20, 1.22\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nCardiac Arrest:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n0.74\n0.70, 0.79\n&lt;0.001\n\n\nAge, y\n1.01\n1.00, 1.01\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.13\n1.09, 1.17\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.17\n1.07, 1.27\n&lt;0.001\n\n\n    Black\n1.18\n1.13, 1.23\n&lt;0.001\n\n\n    Hispanic\n1.14\n1.08, 1.20\n&lt;0.001\n\n\n    Other\n1.23\n1.13, 1.34\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.93\n0.89, 0.97\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.88\n0.84, 0.93\n&lt;0.001\n\n\n    $88,000 or more\n0.89\n0.84, 0.94\n&lt;0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1.03\n0.97, 1.09\n0.3\n\n\n    Other\n1.21\n1.10, 1.34\n&lt;0.001\n\n\n    Private\n1.05\n0.98, 1.13\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.88\n0.83, 0.94\n&lt;0.001\n\n\n    South\n1.16\n1.11, 1.22\n&lt;0.001\n\n\n    West\n1.10\n1.03, 1.17\n0.003\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.14\n1.09, 1.19\n&lt;0.001\n\n\n    Small\n1.08\n1.02, 1.13\n0.007\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.13\n1.03, 1.24\n0.009\n\n\n    Urban, teaching\n1.11\n1.02, 1.21\n0.016\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.79, 1.02\n0.10\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.41\n1.36, 1.46\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n1.18, 1.31\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.80, 0.87\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.90, 0.98\n0.004\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.53\n1.47, 1.59\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.62, 0.90\n0.002\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.54\n0.50, 0.58\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.97, 1.06\n0.6\n\n\nCharlson comorbidity index\n1.07\n1.05, 1.08\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nGastrointestinal Hemorrhage:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n1.01\n0.98, 1.05\n0.3\n\n\nAge, y\n1.02\n1.02, 1.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.96\n0.94, 0.98\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.09\n1.04, 1.15\n&lt;0.001\n\n\n    Black\n1.14\n1.12, 1.17\n&lt;0.001\n\n\n    Hispanic\n0.97\n0.94, 1.00\n0.085\n\n\n    Other\n0.99\n0.94, 1.05\n0.8\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.97\n0.95, 1.0\n0.018\n\n\n    $66,000 - $87,999\n1.00\n0.97, 1.02\n0.8\n\n\n    $88,000 or more\n0.97\n0.94, 1.01\n0.10\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1.11\n1.07, 1.15\n&lt;0.001\n\n\n    Other\n0.98\n0.92, 1.05\n0.6\n\n\n    Private\n1.07\n1.02, 1.11\n0.004\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.96\n0.93, 0.99\n0.015\n\n\n    South\n0.96\n0.93, 0.99\n0.003\n\n\n    West\n0.97\n0.94, 1.00\n0.083\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.00\n0.97, 1.02\n0.7\n\n\n    Small\n0.97\n0.94, 1.00\n0.037\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.07\n1.02, 1.13\n0.008\n\n\n    Urban, teaching\n1.10\n1.05, 1.16\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.91, 1.04\n0.4\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n1.00, 1.04\n0.12\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.70, 0.75\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.80, 0.83\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.54\n0.53, 0.56\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.77, 0.80\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.32\n0.29, 0.35\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.83, 0.90\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.96, 1.01\n0.2\n\n\nCharlson comorbidity index\n1.23\n1.22, 1.23\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n-0.39\n-0.46, -0.32\n&lt;0.001\n\n\nAge, y\n0.02\n0.02, 0.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.17\n0.12, 0.22\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n-0.26\n-0.41, -0.12\n&lt;0.001\n\n\n    Black\n-0.22\n-0.28, -0.15\n&lt;0.001\n\n\n    Hispanic\n-0.53\n-0.64, -0.43\n&lt;0.001\n\n\n    Other\n0.08\n-0.07, 0.23\n0.3\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.01\n-0.07, 0.08\n0.9\n\n\n    $66,000 - $87,999\n0.06\n-0.03, 0.14\n0.2\n\n\n    $88,000 or more\n0.17\n0.06, 0.27\n0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-1.1\n-1.3, -0.99\n&lt;0.001\n\n\n    Other\n-0.42\n-0.62, -0.22\n&lt;0.001\n\n\n    Private\n-0.18\n-0.34, -0.03\n0.022\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.2\n1.1, 1.4\n&lt;0.001\n\n\n    South\n0.81\n0.69, 0.93\n&lt;0.001\n\n\n    West\n0.18\n0.03, 0.33\n0.015\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.92\n-1.0, -0.82\n&lt;0.001\n\n\n    Small\n-1.4\n-1.5, -1.3\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.96\n0.81, 1.1\n&lt;0.001\n\n\n    Urban, teaching\n2.0\n1.8, 2.1\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.91\n-1.0, -0.79\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.59\n-0.64, -0.53\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.6\n1.5, 1.7\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.80\n-0.86, -0.73\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.2, -1.1\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.51, 0.64\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3.0\n-3.3, -2.7\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.8\n-2.0, -1.6\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.64, 0.77\n&lt;0.001\n\n\nCharlson comorbidity index\n0.56\n0.53, 0.59\n&lt;0.001\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n-10,138\n-11,494, -8,782\n&lt;0.001\n\n\nAge, y\n-116\n-155, -77\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,180\n5,326, 7,034\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n6,450\n2,171, 10,728\n0.003\n\n\n    Black\n-4,659\n-6,397, -2,921\n&lt;0.001\n\n\n    Hispanic\n6,263\n3,445, 9,081\n&lt;0.001\n\n\n    Other\n8,685\n4,304, 13,066\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1,315\n-414, 3,045\n0.14\n\n\n    $66,000 - $87,999\n2,838\n744, 4,932\n0.008\n\n\n    $88,000 or more\n11,572\n8,317, 14,827\n&lt;0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-531\n-2,910, 1,848\n0.7\n\n\n    Other\n449\n-3,134, 4,032\n0.8\n\n\n    Private\n22,539\n18,690, 26,387\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n30,614\n25,131, 36,097\n&lt;0.001\n\n\n    South\n20,114\n16,792, 23,436\n&lt;0.001\n\n\n    West\n48,732\n42,061, 55,404\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-20,163\n-23,996, -16,330\n&lt;0.001\n\n\n    Small\n-31,823\n-35,856, -27,791\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n34,533\n31,182, 37,884\n&lt;0.001\n\n\n    Urban, teaching\n51,575\n48,226, 54,924\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16,287\n-19,124, -13,450\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n641\n-512, 1,793\n0.3\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n24,735\n22,585, 26,886\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-14,079\n-15,503, -12,655\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-24,708\n-26,808, -22,608\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n6,662\n5,245, 8,078\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-46,770\n-53,281, -40,258\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-33,201\n-37,868, -28,533\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n12,758\n11,429, 14,087\n&lt;0.001\n\n\nCharlson comorbidity index\n8,209\n7,567, 8,850\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]